{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:41:44Z","timestamp":1648989704210},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2001,4,1]],"date-time":"2001-04-01T00:00:00Z","timestamp":986083200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2001,4]]},"DOI":"10.1007\/s11908-996-0057-x","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T17:39:37Z","timestamp":1180719577000},"page":"183-192","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic complications of HIV and AIDS"],"prefix":"10.1007","volume":"3","author":[{"given":"Alison","family":"Strawford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc K.","family":"Hellerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"57_CR1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/ajcn\/50.3.444","volume":"50","author":"DP Kotler","year":"1989","unstructured":"Kotler DP, Tierney A, Wang J, et al.: Magnitude of body cell mass depletion and timing of death from wasting in AIDS. Am J Clin Nutr 1989, 50:444\u2013447.","journal-title":"Am J Clin Nutr"},{"key":"57_CR2","first-page":"1130","volume":"6","author":"P Guenter","year":"1993","unstructured":"Guenter P, Murahainen N, Simons G, et al.: Relationships among nutritional status, disease progression and survival in HIV infection. J Acquir Immunodefic Syndr Retrovirol 1993, 6:1130\u20131138.","journal-title":"J Acquir Immunodefic Syndr Retrovirol"},{"issue":"suppl 6","key":"57_CR3","first-page":"76","volume":"25","author":"A Strawford","year":"1998","unstructured":"Strawford A, Hellerstein M: The etiology of wasting in HIV\/ AIDS. Semin Oncol 1998, 25(suppl 6):76\u201381.","journal-title":"Semin Oncol"},{"issue":"suppl 9","key":"57_CR4","first-page":"17","volume":"17","author":"MK Hellerstein","year":"1990","unstructured":"Hellerstein MK, Kahn J, Mudie H, et al.: Current approach to the treatment of HIV associated weight loss: pathophysiologic considerations and emerging management strategies. Semin Oncol 1990, 17(suppl 9):17\u201333.","journal-title":"Semin Oncol"},{"key":"57_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-2007-1007389","volume":"12","author":"C Grunfeld","year":"1992","unstructured":"Grunfeld C, Kotler DP: Wasting in AIDS. Semin Liver Dis 1992, 12:175\u2013187.","journal-title":"Semin Liver Dis"},{"key":"57_CR6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00002030-199813000-00012","volume":"12","author":"M Silva","year":"1998","unstructured":"Silva M, Skolnik P, Gorbach S, et al.: The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS 1998, 12:1645\u20131651.","journal-title":"AIDS"},{"key":"57_CR7","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998, 12:F51\u201358. The first large, systematic cross-sectional study describing lipodystrophy in patients with HIV infection or AIDS receiving protease inhibitor therapy.","journal-title":"AIDS"},{"key":"57_CR8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","volume":"353","author":"A Carr","year":"1999","unstructured":"Carr A, Samaras K, Thorisdottir A, et al.: Diagnosis, prediction and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 1999, 353:2093\u20132099. A natural history study observing the prevalence and severity of lipodystrophy over time in patients with HIV infection or AIDS receiving protease inhibitor therapy.","journal-title":"Lancet"},{"key":"57_CR9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","volume":"13","author":"T Saint-Marc","year":"1999","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, et al.: A syndrome of peripheral fat wasting in patients receiving long term nucleoside analogue therapy. AIDS 1999, 13:1659\u20131667. This study reported lipodystrophy in protease inhibitor-naive patients who were taking NRTI therapy. It also suggested a link between stavudine therapy and lower percentage of body fat, which partially reversed in a subgroup of patients who discontinued therapy.","journal-title":"AIDS"},{"key":"57_CR10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","volume":"14","author":"T Saint-Marc","year":"2000","unstructured":"Saint-Marc T, Partisani M, Poizot-Martin I, et al.: Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 2000, 14:37\u201349. This systematic review addressed fat abnormalities in a large selection of HIV-infected patients receiving various anitretroviral therapies. It suggests that three types of fat redistribution may occur: fat depletion, mixed or fat redistribution syndrome, and subcutaneous adiposity.","journal-title":"AIDS"},{"key":"57_CR11","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","volume":"14","author":"A Carr","year":"2000","unstructured":"Carr A, Miller A, Law M, et al.: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000, 14:F25-F32. This study documents lipodystrophy in protease inhibitor-na:ive, NRTI recipients. Symptoms of lipodystrophy included fatigue, abdominal distention, and elevated lactate levels. It suggests that although both protease inhibitors and NRTIs contribute to lipodystrophy, their effects may be distinguishable.","journal-title":"AIDS"},{"key":"57_CR12","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(05)79053-X","volume":"351","author":"K Henry","year":"1998","unstructured":"Henry K, Melroe H, Huebsch J, et al.: Severe premature coronary artery disease with protease inhibitors. Lancet 1998, 351:1328.","journal-title":"Lancet"},{"issue":"suppl 2","key":"57_CR13","first-page":"54","volume":"4","author":"P Maggi","year":"1999","unstructured":"Maggi P, Fiorentino G, Saracino A, et al.: Precocious lesions of the carotid vessels in HIV-1 infected patients treated with protease inhibitors. Antiviral Ther 1999, 4(suppl 2):54.","journal-title":"Antiviral Ther"},{"key":"57_CR14","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1097\/00002030-199815000-00001","volume":"12","author":"R Walli","year":"1998","unstructured":"Walli R, Herfort O, Michl G, et al.: Treatment with protease inhibitors associated with peripheral insulin resistance and impaired glucose tolerance in HIV-1 infected patients. AIDS 1998, 12:F167-F173.","journal-title":"AIDS"},{"key":"57_CR15","unstructured":"Ward D, Delaney K, Moorman K, et al.: Description of lipodystrophy in the HIV Outpatient Study (HOPS) [abstract]. In 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: September 26\u201329, 1999."},{"key":"57_CR16","unstructured":"Falutz J, Turcot D: Considerations in the development of a case definition for HIV\/HAART associated lipodystrophy syndrome [abstract]. In First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Francisco: June 26\u201328, 1999."},{"key":"57_CR17","unstructured":"El Sadr WM, Collins G, Raghavan S: Prevalence of metabolic complications in a large diverse cohort of HIV-infected persons [abstract]. In Program and Abstracts of the 7th Conference on Antiretroviruses and Opportunistic Infections. San Francisco: January 29\u2013February 2, 2000."},{"key":"57_CR18","unstructured":"Regan AM, Babl FE: Abnormal body fat accumulations in HIV-infected children on antiretroviral therapy [abstract]. In Program and Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherpy. San Diego: September, 1998."},{"key":"57_CR19","unstructured":"Arpadi S, Cuff P, Kotler D, et al.: Changes in regional fat distribution in HIV-infected children [abstract]. In Program and Abstracts of the 7th Conference on Retroviruses and Opportunistic Infections. San Francisco: January 30\u2013February 2, 2000."},{"key":"57_CR20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199507133330202","volume":"333","author":"DC Macallan","year":"1995","unstructured":"Macallan DC, Noble C, Baldwin C, et al.: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995, 333:83\u201388.","journal-title":"N Engl J Med"},{"key":"57_CR21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1177\/0148607190014005454","volume":"14","author":"DP Kotler","year":"1990","unstructured":"Kotler DP, Tierney A, Culpepper-Morgan J, et al.: Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. J Parenter Enter Nutr 1990, 14:454\u2013458.","journal-title":"J Parenter Enter Nutr"},{"key":"57_CR22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-121-6-199409150-00001","volume":"121","author":"JH Roenn Von","year":"1994","unstructured":"Von Roenn JH, Armstrong D, Kotler DP, et al.: Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 1994, 121:393\u2013399.","journal-title":"Ann Intern Med"},{"key":"57_CR23","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0002-9343(88)90144-1","volume":"84","author":"AS Dobs","year":"1988","unstructured":"Dobs AS, Dempseymegestrol acetate, Landenson PW, et al.: Endocrine disorders in men infected with HIV. Am J Med 1988, 84:611\u2013616.","journal-title":"Am J Med"},{"key":"57_CR24","first-page":"559","volume":"76","author":"MK Hellerstein","year":"1993","unstructured":"Hellerstein MK, Grunfeld C, Wu K, et al.: Increased de novo lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 76:559\u2013565.","journal-title":"J Clin Endocrinol Metab"},{"key":"57_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.1996.705526.x","volume":"44","author":"RA Frost","year":"1996","unstructured":"Frost RA, Fuhrer J, Steigbigel R, et al.: Wasting in the acquired immunodeficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system. Clin Endocrinol 1996, 44:501\u2013514.","journal-title":"Clin Endocrinol"},{"key":"57_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1042\/cs0910241","volume":"91","author":"NI Paton","year":"1996","unstructured":"Paton NI, Elia M, Jennings G, et al.: Total energy expenditure and physical activity measured with the bicarbonate-urea method in patients with human immunodeficiency virus infection. Clin Sci 1996, 91:241\u201345.","journal-title":"Clin Sci"},{"key":"57_CR27","unstructured":"Beach R: Side effects of dronabinol in the treatment of AIDS related weight loss [abstract]. In Program and Abstracts: Ninth International Conference on AIDS. Berlin: June 6\u201311, 1993."},{"key":"57_CR28","first-page":"1107","volume":"9","author":"ES Engelson","year":"1995","unstructured":"Engelson ES, Kotler DP: Effects of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS. AIDS 1995, 9:1107\u20131108.","journal-title":"AIDS"},{"key":"57_CR29","doi-asserted-by":"crossref","unstructured":"Strawford A, Hoh R, Neese R, et al.: The effects of combination megestrol acetate and testosterone replacement therapy in AIDS wasting syndrome [abstract]. In 2nd International Conference on Nutrition in HIV infection. Cannes, France: April 1997.","DOI":"10.1016\/S0899-9007(97)82654-8"},{"key":"57_CR30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/00042560-199603010-00006","volume":"11","author":"MK Hellerstein","year":"1996","unstructured":"Hellerstein MK, Wu K, McGrath M, et al.: Effects of dietary n-3 fatty acid supplementation in men with weight loss associated with the acquired immunodeficiency syndrome: relation to indices of cytokine production. J Acquir Immunodefic Syndr Retrovirol 1996, 11:258\u2013270.","journal-title":"J Acquir Immunodefic Syndr Retrovirol"},{"key":"57_CR31","first-page":"787","volume":"6","author":"BJ Dezube","year":"1993","unstructured":"Dezube BJ, Pardee AB, Chapman B, et al.: Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J Acquir Immunodefic Syndr Retrovirol 1993, 6:787\u2013794.","journal-title":"J Acquir Immunodefic Syndr Retrovirol"},{"key":"57_CR32","first-page":"956","volume":"77","author":"K Mulligan","year":"1993","unstructured":"Mulligan K, Grunfeld C, Hellerstein MK, et al.: Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 77:956\u2013962.","journal-title":"J Clin Endocrinol Metab"},{"key":"57_CR33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","volume":"125","author":"M Schambelan","year":"1996","unstructured":"Schambelan M, Mulligan K, Grunfeld C, et al.: Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med 1996, 125:873\u2013882.","journal-title":"Ann Intern Med"},{"key":"57_CR34","first-page":"245","volume":"6","author":"A Krentz","year":"1993","unstructured":"Krentz A, Koster F, Crist D, et al.: Anthropometric, metabolic and immunological effects of human growth hormone in AIDS and AIDS related complex. J Acquir Immunodefic Syndr Retrovirol 1993, 6:245\u2013251.","journal-title":"J Acquir Immunodefic Syndr Retrovirol"},{"key":"57_CR35","first-page":"404","volume":"78","author":"SA Lieberman","year":"1994","unstructured":"Lieberman SA, Butterfield GE, Harrison D, et al.: Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with AIDS. J Clin Endocrinol Metab 1994, 78:404\u2013410.","journal-title":"J Clin Endocrinol Metab"},{"key":"57_CR36","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/00002030-199711000-00008","volume":"11","author":"GO Coodley","year":"1997","unstructured":"Coodley GO, Coodley MK: A trial of testosterone therapy for HIV-associated weight loss. AIDS 1997, 11:1347\u20131352.","journal-title":"AIDS"},{"key":"57_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7326\/0003-4819-129-1-199807010-00005","volume":"129","author":"S Grinspoon","year":"1998","unstructured":"Grinspoon S, Corcoran C, Askari H, et al.: Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 129:18\u201326.","journal-title":"Ann Intern Med"},{"key":"57_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00042560-199902010-00005","volume":"20","author":"A Strawford","year":"1999","unstructured":"Strawford A, Barbieri T, Neese R, et al.: Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss. J Acquir Immune Defic Syndr Hum Retrovirol 1999, 20:137\u2013146.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"57_CR39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00002030-199902040-00011","volume":"13","author":"R Roubennoff","year":"1999","unstructured":"Roubennoff R, McDermott A, Weiss L, et al.: Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus. AIDS 1999, 13:231\u2013239.","journal-title":"AIDS"},{"key":"57_CR40","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.281.14.1282","volume":"281","author":"A Strawford","year":"1999","unstructured":"Strawford A, Barbieri T, Neese R, et al.: The effects of oxandrolone plus resistance exercise on nitrogen balance, body composition and strength in men with HIV\/AIDS-related wasting. JAMA 1999, 281:1282\u20131290.","journal-title":"JAMA"},{"key":"57_CR41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","volume":"351","author":"J Lo","year":"1998","unstructured":"Lo J, Mulligan K, Tai V, et al.: \"Buffalo hump\" in men with HIV-1 infection. Lancet 1998, 351:867\u2013875.","journal-title":"Lancet"},{"key":"57_CR42","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0140-6736(05)64011-1","volume":"350","author":"R Hengel","year":"1997","unstructured":"Hengel R, Watts N, Lennox J: Benign symmetric lipomatosis associated with protease inhibitors. Lancet 1997, 350:1596.","journal-title":"Lancet"},{"key":"57_CR43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","volume":"351","author":"K Miller","year":"1998","unstructured":"Miller K, Jones E, Yanovski J, et al.: Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998, 351:871\u2013875.","journal-title":"Lancet"},{"key":"57_CR44","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","volume":"12","author":"R Viraben","year":"1997","unstructured":"Viraben R, Aquilina C: Indinavir-associated lipodystrophy. AIDS 1997, 12:F37-F39.","journal-title":"AIDS"},{"key":"57_CR45","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(05)60719-2","volume":"352","author":"E Martinez","year":"1998","unstructured":"Martinez E, Gatell J: Metabolic abnormalities and the use of HIV-1 protease inhibitors. Lancet 1998, 352:821\u2013822.","journal-title":"Lancet"},{"key":"57_CR46","unstructured":"Garg A: Genetic and acquired lipodystrophy syndromes syndromes [abstract]. In Program and Abstracts of the First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego: June 26\u201328, 1999."},{"key":"57_CR47","first-page":"1883","volume-title":"Harrison\u2019s Principles of Internal Medicine","author":"DW Foster","year":"1991","unstructured":"Foster DW: The lipodystrophies and other rare disorders of adipose tissue. In Harrison\u2019s Principles of Internal Medicine, edn 12. Edited by Wilson JD. New York: McGraw-Hill; 1991:1883\u20131885.","edition":"edn 12"},{"key":"57_CR48","unstructured":"Kotler D: Update on morphologic and metabolic abnormalities in HIV: etiology and reversibility of lipodystrophy. HIV\/AIDS Treatment Up-dates. Medscape: December 16, 1999. Available online at http:\/\/www.medscape.com\/medscape\/HIV\/ TreatmentUpdate\/1999\/tu11\/public\/toc-tu11.html."},{"key":"57_CR49","unstructured":"Boix V, Reus S, Priego M, et al.: Expanding the spectrum of protease inhibitors-induced lipodystrophy [abstract]. In 12th World AIDS Conference. Geneva, Switzerland: June, 1998."},{"key":"57_CR50","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","volume":"13","author":"C Gervasoni","year":"1999","unstructured":"Gervasoni C, Ridolfo AL, Trifiro G, et al.: Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy. AIDS 1999, 13:465\u2013471.","journal-title":"AIDS"},{"key":"57_CR51","first-page":"107","volume":"21","author":"K Dong","year":"1999","unstructured":"Dong K, Bausserman LL, Flynn MM, et al.: Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr Hum Retrovirol 1999, 21:107\u2013113.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"57_CR52","unstructured":"Viard JP, Rakotoambinina B: Lipodystrophic syndromes in a cohort of HIV-1 infected patients receiving HAART with a protease inhibitor [abstract]. In Program and Abstracts from the First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego: June 26\u201328, 1999."},{"key":"57_CR53","unstructured":"Miro JM, Martinez E, Garcia F, et al.: Incidence of lipodystrophy in patients with pimary HIV infection treated with HAART [abstract]. In Program and Abstracts of the 7th Conference on Antiretroviruses and Opportunistic Infections. San Francisco: January 29\u2013February 2, 2000."},{"key":"57_CR54","unstructured":"Muurahainen N, Falutz J, Pettit R, et al.: HIV-associated adipose redistribution syndrome (HARS) overweight patients report less lipodystrophy, more fat accumulation [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: September 26\u201329, 1999."},{"key":"57_CR55","unstructured":"Polo R, Verdejo J, Gonzalae-Munoz M, et al.: Lipid evaluation and glucose metabolism in HIV-infected patients before and after initiation of protease inhibitor therapy [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: September 26\u201329, 1999."},{"key":"57_CR56","unstructured":"Boxwell DE, Styrt BA: Lactic acidosis in patients receiving nucleoside reverse transcriptase inhibitors [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: September 26\u201329, 1999."},{"key":"57_CR57","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/00002030-199814000-00004","volume":"12","author":"K Brinkman","year":"1998","unstructured":"Brinkman K, Hofstede JM, Burger D, et al.: Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as a common pathway. AIDS 1998, 12:1735\u20131744.","journal-title":"AIDS"},{"key":"57_CR58","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.410290519","volume":"29","author":"SF Berkovic","year":"1991","unstructured":"Berkovic SF, Andermann F, Shoubridge EA, et al.: Mitochondrial dysfunction in multiple symmetric lipamotosis. Ann Neurol 1991, 29:566\u2013569.","journal-title":"Ann Neurol"},{"key":"57_CR59","first-page":"625","volume":"39","author":"CH Chen","year":"1991","unstructured":"Chen CH, Vazquez Padua M, Myers CE, et al.: Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DN and its implication for delayed toxicity. Mol Pharmacol 1991, 39:625\u2013628.","journal-title":"Mol Pharmacol"},{"key":"57_CR60","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0149-2918(00)90004-3","volume":"22","author":"TN Kakuda","year":"2000","unstructured":"Kakuda TN: Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther 2000, 22:685\u2013708.","journal-title":"Clin Ther"},{"key":"57_CR61","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","volume":"13","author":"P Domingo","year":"1999","unstructured":"Domingo P, Matias-Guiu X, Pujol R, et al.: Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 1999, 13:2261\u20132267.","journal-title":"AIDS"},{"key":"57_CR62","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1097\/00002030-199912240-00002","volume":"13","author":"S Safrin","year":"1999","unstructured":"Safrin S, Grunfeld C: Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999, 13:2493\u20132505.","journal-title":"AIDS"},{"key":"57_CR63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/ajcn\/70.5.787","volume":"70","author":"MK Hellerstein","year":"1999","unstructured":"Hellerstein MK: The changing face of AIDS: translators needed. Am J Clin Nutr 1999, 70:787\u2013788.","journal-title":"Am J Clin Nutr"},{"key":"57_CR64","unstructured":"Ruiz L, Negerdo E, Bonjoch A, et al.: A multicentre, randomized, open-label, comparative trial of the clinical, immunological and virological benefit of switching the PI nevaripine in HAART-experienced patients suffering lipodystrophy [abstract]. In Program and Abstracts of the First International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. San Diego: June 26\u201328, 1999."},{"key":"57_CR65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/00002030-199905070-00009","volume":"13","author":"E Martinez","year":"1999","unstructured":"Martinez E, Conget I, Lozano L, et al.: Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevaripine. AIDS 1999, 13:805\u2013810.","journal-title":"AIDS"},{"key":"57_CR66","unstructured":"Moyle GJ, Baldwin C, Dent N, et al.: Maintenance of viral suppression but incomplete resolution of metabolic and clinical lipid abnormalities in persons switched from protease (PI) based to efavirenz (EFV) based therapy [abstract]. In Program and Abstracts of the Seventh European Conference on Clinical Aspects and Treatment of HIV Infection. Lisbon, Portugal: October 23\u201327, 1999."},{"key":"57_CR67","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/00002030-199907300-00015","volume":"13","author":"R Roubenoff","year":"1999","unstructured":"Roubenoff R, Weiss L, McDermott A, et al.: A pilot study of exercise training to reduce trunk fat in adults with HIV-associated fat redistribution. AIDS 1999, 13:1373\u20131375.","journal-title":"AIDS"},{"key":"57_CR68","unstructured":"Dietrich D, Aymat R, Braun J, et al.: Incidence of body habitus changes in a cohort of 725 HIV-infected patients [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago: January 31\u2013February 4, 1999."},{"key":"57_CR69","first-page":"291","volume":"20","author":"P Marin","year":"1992","unstructured":"Marin P, Holmang S, Jonsson L, et al.: The effects of testosterone treatment on body composition in middle aged obese men. Int J Obes Relat Metab Dis 1992, 20:291\u2013302.","journal-title":"Int J Obes Relat Metab Dis"},{"key":"57_CR70","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1258\/0956462981921080","volume":"9","author":"C O\u2019Mahony","year":"1998","unstructured":"O\u2019Mahony C, Price L, Nelson M: Lipodystrophy despite anabolic steroids [letter]. Int J STD AIDS 1998, 9:619.","journal-title":"Int J STD AIDS"},{"key":"57_CR71","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00002030-199910220-00013","volume":"13","author":"C Wanke","year":"1999","unstructured":"Wanke C, Gerrior J, Kantaros J, et al.: Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV. AIDS 1999, 13:2099\u20132103.","journal-title":"AIDS"},{"key":"57_CR72","unstructured":"Santos GA, Finkelstein J, Pettit R: Management of HIV-associated adipose redistribution syndrome (HARS) in women with low dose recombinant human growth hormone (rhGH) [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: September 26\u201329, 1999."},{"key":"57_CR73","unstructured":"Torres R, Unger K: The effect of recombinant human growth hormone on protease-inhibitor-associated fat maldistribution syndrome [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago: January 31\u2013February 4, 1999."},{"key":"57_CR74","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.284.4.472","volume":"284","author":"C Hadigan","year":"2000","unstructured":"Hadigan C, Corcoran C, Davis B, et al.: Metformin in the treatment of HIV liodystrophy syndrome. JAMA 2000, 284:472\u2013477. The first double-blind, placebo-controlled study of a treatment approach for lipodystrophy. The trial suggests that metformin may decrease abdominal girth and reduce weight, blood pressure, and insulin levels in the absence of elevations in lactate levels (a potential side effect of metformin therapy).","journal-title":"JAMA"},{"key":"57_CR75","unstructured":"Henry K, Melroe H, Huebesch J, et al.: Experience with the National Cholesterol Education Program (NCEP) guidelines for the identification and treatment of protease inhibitor related lipid abnormalities: results of a prospective study [abstract]. In Program and Abstracts of the 6th Conference on Retroviruses and Opportunistic Infections. Chicago: January 31\u2013February 4, 1999."}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-996-0057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11908-996-0057-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-996-0057-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:24:21Z","timestamp":1559420661000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11908-996-0057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1007\/s11908-996-0057-x","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4]]}}}